NurExone Biologic Inc. (TSXV:NRX)
Canada · Delayed Price · Currency is CAD 0.6000
-0.0900 (-13.04%)
Sep 18, 2026, 2:43 PM EST
NurExone Biologic Market Cap
NurExone Biologic has a market cap or net worth of CAD 57.84 million as of September 18, 2026. Its market cap has decreased by -34.41% in one year.
Market Cap
57.84M
Enterprise Value
56.48M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.60
ChartMarket Cap Chart
Since June 23, 2022, NurExone Biologic's market cap has increased from 33.48M to 57.84M, an increase of 72.74%. That is a compound annual growth rate of 13.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 57.84M | -3.36% |
| Dec 31, 2025 | 59.85M | 36.16% |
| Dec 31, 2024 | 43.95M | 208.80% |
| Dec 28, 2023 | 14.23M | -14.84% |
| Dec 22, 2022 | 16.71M | -50.08% |
| Jun 23, 2022 | 33.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ME Therapeutics Holdings | 53.18M |
| BriaCell Therapeutics | 51.42M |
| MedMira | 45.61M |
| Sona Nanotech | 43.59M |
| Sharp Therapeutics | 43.26M |
| Microbix Biosystems | 41.09M |
| Sernova Biotherapeutics | 39.65M |
| Medicenna Therapeutics | 39.23M |